Log in
NASDAQ:ADMA

ADMA Biologics Earnings Date, Estimates & History

$2.18
+0.14 (+6.86 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$2.02
Now: $2.18
$2.20
50-Day Range
$2.04
MA: $2.58
$3.13
52-Week Range
$1.45
Now: $2.18
$5.25
Volume1.86 million shs
Average Volume3.74 million shs
Market Capitalization$188.24 million
P/E RatioN/A
Dividend YieldN/A
Beta1.98

Earnings

ADMA Biologics (NASDAQ:ADMA) Earnings Information

ADMA Biologics last posted its quarterly earnings results on August 5th, 2020. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by $0.07. The firm had revenue of $7.79 million for the quarter, compared to the consensus estimate of $10.29 million. ADMA Biologics has generated ($0.92) earnings per share over the last year. ADMA Biologics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 4th, 2020 based off prior year's report dates.

ADMA Biologics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ADMA Biologics (NASDAQ:ADMA) Earnings Estimates

2020 EPS Consensus Estimate: ($0.46)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($0.13)($0.01)($0.08)
Q2 20202($0.15)($0.10)($0.13)
Q3 20202($0.16)($0.09)($0.13)
Q4 20202($0.18)($0.08)($0.13)
Q1 20211($0.18)($0.18)($0.18)
Q2 20211($0.16)($0.16)($0.16)

ADMA Biologics (NASDAQ ADMA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/4/2020
(Estimated)
       
8/5/2020Q2 2020($0.1570)($0.23)($0.23)$10.29 million$7.79 millionTranscript
5/6/2020Q1 2020($0.13)($0.26)($0.26)$10.71 million$10.20 millionN/A
3/12/202012/31/2019($0.17)($0.18)($0.18)$11.92 million$12.04 millionTranscript
11/6/2019Q3($0.23)($0.19)($0.19)$5.71 million$7.22 millionN/A
8/8/2019Q2 2019($0.2870)($0.25)($0.25)$4.36 million$6.56 millionN/A
5/8/2019Q1 2019($0.32)($0.31)($0.34)$2.96 million$3.53 millionN/A
3/13/2019Q4 2018($0.33)($0.39)($0.39)$5.19 million$4.06 millionN/A
11/8/2018Q3($0.31)($0.33)($0.33)$5.39 million$4.23 millionN/A
8/10/2018Q2 2018($0.32)($0.35)($0.35)$5.35 million$4.66 millionN/A
5/14/2018Q1 2018($0.27)($0.35)($0.31)$7.47 million$4.04 millionN/A
3/5/2018Q4 2017($0.51)($0.24)($0.24)$6.68 million$12.00 millionN/A
11/3/2017Q3 2017($0.51)$0.59$0.59$6.86 million$4.73 millionN/A
8/11/2017Q2 2017($0.26)($0.55)($0.55)$3.52 million$3.40 millionN/A
5/12/2017Q1 2017($0.2830)($0.51)($0.51)$3.35 million$2.63 millionN/A
2/24/2017Q4 2016($0.33)($0.35)($0.35)$2.80 million$3.33 millionN/A
11/10/2016Q3 2016($0.42)($0.34)($0.34)$2.32 million$2.94 millionN/A
8/12/2016Q2($0.39)($0.50)($0.50)$2.35 million$2.27 millionN/A
5/13/2016Q1($0.37)($0.43)($0.43)$2.48 million$2.12 millionN/A
3/23/2016Q4 2015($0.47)($0.44)($0.44)$2.03 million$2.51 millionN/A
11/10/2015Q315($0.39)($0.48)($0.48)$1.50 million$1.85 millionN/A
8/11/2015Q215($0.32)($0.37)($0.30)$1.50 million$1.30 millionN/A
5/12/2015Q115($0.32)($0.37)($0.37)$1.50 million$1.50 millionN/A
3/9/2015Q4 2014($0.38)($0.38)($0.38)$1.52 million$1.41 millionN/A
11/10/2014Q3 2014($0.37)($0.36)($0.36)$1.37 millionN/A
8/11/2014Q2 2014($0.43)($0.43)$1.50 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.